119 related articles for article (PubMed ID: 35994794)
21. Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials.
Faron M; Pignon JP; Malka D; Bourredjem A; Douillard JY; Adenis A; Elias D; Bouché O; Ducreux M
Eur J Cancer; 2015 Jan; 51(2):166-76. PubMed ID: 25465185
[TBL] [Abstract][Full Text] [Related]
22. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.
Bambha KM; Dodge JL; Gralla J; Sprague D; Biggins SW
Liver Transpl; 2015 Oct; 21(10):1286-94. PubMed ID: 26097202
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Value of Baseline ALBI Score Among Patients With Colorectal Liver Metastases: A Pooled Analysis of Two Randomized Trials.
Abdel-Rahman O
Clin Colorectal Cancer; 2019 Mar; 18(1):e61-e68. PubMed ID: 30348618
[TBL] [Abstract][Full Text] [Related]
24. Survival Outcomes in Patients With RAS Wild Type Metastatic Colorectal Cancer Classified According to Köhne Prognostic Category and BRAF Mutation Status.
Siena S; Rivera F; Taieb J; Peeters M; Prenen H; Koukakis R; Demonty G; Köhne CH
Clin Colorectal Cancer; 2018 Mar; 17(1):50-57.e8. PubMed ID: 29096990
[TBL] [Abstract][Full Text] [Related]
25. Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial.
Martel S; Lambertini M; Agbor-Tarh D; Ponde NF; Gombos A; Paterson V; Hilbers F; Korde L; Manukyants A; Dueck A; Maurer C; Piccart M; Moreno-Aspitia A; Desmedt C; Di Cosimo S; de Azambuja E
J Natl Compr Canc Netw; 2021 Jan; 19(2):181-189. PubMed ID: 33401235
[TBL] [Abstract][Full Text] [Related]
26. The Effect of Weight Change During Treatment With Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma.
McKay RR; Vu P; Albiges LK; Lin X; Simantov R; Temel JS; Choueiri TK
Clin Genitourin Cancer; 2019 Dec; 17(6):443-450.e1. PubMed ID: 31601515
[TBL] [Abstract][Full Text] [Related]
27. Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405.
Guercio BJ; Zhang S; Ou FS; Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; O'Neil BH; Shaw JE; Polite BN; Hochster HS; Atkins JN; Goldberg RM; Sato K; Ng K; Van Blarigan E; Mayer RJ; Blanke CD; O'Reilly EM; Fuchs CS; Meyerhardt JA
J Clin Oncol; 2019 Oct; 37(29):2620-2631. PubMed ID: 31408415
[TBL] [Abstract][Full Text] [Related]
28. Muscle Loss Is Associated with Overall Survival in Patients with Metastatic Colorectal Cancer Independent of Tumor Mutational Status and Weight Loss.
Best TD; Roeland EJ; Horick NK; Van Seventer EE; El-Jawahri A; Troschel AS; Johnson PC; Kanter KN; Fish MG; Marquardt JP; Bridge CP; Temel JS; Corcoran RB; Nipp RD; Fintelmann FJ
Oncologist; 2021 Jun; 26(6):e963-e970. PubMed ID: 33818860
[TBL] [Abstract][Full Text] [Related]
29. Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405.
Guercio BJ; Zhang S; Venook AP; Ou FS; Niedzwiecki D; Lenz HJ; Innocenti F; Mullen BC; O'Neil BH; Shaw JE; Polite BN; Hochster HS; Atkins JN; Goldberg RM; Brown JC; O'Reilly EM; Mayer RJ; Blanke CD; Fuchs CS; Meyerhardt JA
JNCI Cancer Spectr; 2020 Jun; 4(3):pkaa024. PubMed ID: 33134818
[TBL] [Abstract][Full Text] [Related]
30. CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis.
Gao JJ; Cheng J; Bloomquist E; Sanchez J; Wedam SB; Singh H; Amiri-Kordestani L; Ibrahim A; Sridhara R; Goldberg KB; Theoret MR; Kluetz PG; Blumenthal GM; Pazdur R; Beaver JA; Prowell TM
Lancet Oncol; 2020 Feb; 21(2):250-260. PubMed ID: 31859246
[TBL] [Abstract][Full Text] [Related]
31. Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review.
Goey KK; 't Lam-Boer J; de Wilt JH; Punt CJ; van Oijen MG; Koopman M
Eur J Cancer; 2016 Dec; 69():166-177. PubMed ID: 27821320
[TBL] [Abstract][Full Text] [Related]
32. Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306).
Liu L; Erickson NT; Ricard I; von Weikersthal LF; Lerch MM; Decker T; Kiani A; Kaiser F; Heintges T; Kahl C; Kullmann F; Scheithauer W; Link H; Höffkes HG; Moehler M; Gesenhues AB; Theurich S; Michl M; Modest DP; Algül H; Stintzing S; Heinemann V; Holch JW
Int J Cancer; 2022 Jan; 150(1):112-123. PubMed ID: 34431518
[TBL] [Abstract][Full Text] [Related]
33. Body weight management in overweight and obese breast cancer survivors.
Shaikh H; Bradhurst P; Ma LX; Tan SYC; Egger SJ; Vardy JL
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012110. PubMed ID: 33305350
[TBL] [Abstract][Full Text] [Related]
34. Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population.
Meyerhardt JA; Kroenke CH; Prado CM; Kwan ML; Castillo A; Weltzien E; Cespedes Feliciano EM; Xiao J; Caan BJ
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):30-37. PubMed ID: 27986654
[TBL] [Abstract][Full Text] [Related]
35. Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials.
Jiménez-Fonseca P; Sastre J; García-Alfonso P; Gómez-España MA; Salud A; Gil S; Rivera F; Reina JJ; Quintero G; Valladares-Ayerbes M; Safont MJ; La Casta A; Robles-Díaz L; García-Paredes B; López López R; Guillot M; Gallego J; Alonso-Orduña V; Diaz-Rubio E; Aranda E;
Clin Colorectal Cancer; 2023 Jun; 22(2):222-230. PubMed ID: 36944559
[TBL] [Abstract][Full Text] [Related]
36. Yttrium-90 Hepatic Radioembolization for Advanced Chemorefractory Metastatic Colorectal Cancer: Survival Outcomes Based on Right- Versus Left-Sided Primary Tumor Location.
Wu V; Li MD; Goodwin JS; Wehrenberg-Klee EP; Zurkiya O; Kalva SP; Ganguli S
AJR Am J Roentgenol; 2021 Nov; 217(5):1141-1152. PubMed ID: 33594907
[No Abstract] [Full Text] [Related]
37. Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trial.
Pietrantonio F; Fucà G; Manca P; Pagani F; Raimondi A; Prisciandaro M; Randon G; Corti F; de Braud F; Cremolini C; Miceli R
Tumori; 2021 Aug; 107(4):353-359. PubMed ID: 33021466
[TBL] [Abstract][Full Text] [Related]
38. Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis.
Yin J; Dawood S; Cohen R; Meyers J; Zalcberg J; Yoshino T; Seymour M; Maughan T; Saltz L; Van Cutsem E; Venook A; Schmoll HJ; Goldberg R; Hoff P; Hecht JR; Hurwitz H; Punt C; Diaz Rubio E; Koopman M; Cremolini C; Heinemann V; Tournigard C; Bokemeyer C; Fuchs C; Tebbutt N; Souglakos J; Doulliard JY; Kabbinavar F; Chibaudel B; de Gramont A; Shi Q; Grothey A; Adams R
Ther Adv Med Oncol; 2021; 13():17588359211020547. PubMed ID: 34262614
[TBL] [Abstract][Full Text] [Related]
39. Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancer.
Shah MS; Fogelman DR; Raghav KP; Heymach JV; Tran HT; Jiang ZQ; Kopetz S; Daniel CR
Cancer; 2015 Sep; 121(17):2968-75. PubMed ID: 25975416
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
